Sec. 704. Use by Department of Veterans Affairs of commercial institutional review boards in sponsored research trials
256 words·~1 min read·
/bill/116/s/785/es/section-704A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 90 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall complete all necessary policy revisions within the directive of the Veterans Health Administration numbered 1200.05 and titled Requirements for the Protection of Human Subjects in Research , to allow sponsored clinical research of the Department of Veterans Affairs to use accredited commercial institutional review boards to review research proposal protocols of the Department.
Not later than 90 days after the completion of the policy revisions under subsection (a), the Secretary shall— identify accredited commercial institutional review boards for use in connection with sponsored clinical research of the Department; and establish a process to modify existing approvals in the event that a commercial institutional review board loses its accreditation during an ongoing clinical trial. Not later than 90 days after the completion of the policy revisions under subsection (a), and annually thereafter, the Secretary shall submit to the Committee on Veterans’ Affairs of the Senate and the Committee on Veterans’ Affairs of the House of Representatives a report on all approvals of institutional review boards used by the Department, including central institutional review boards and commercial institutional review boards.
The report required by paragraph
(1)shall include, at a minimum, the following: The name of each clinical trial with respect to which the use of an institutional review board has been approved. The institutional review board or institutional review boards used in the approval process for each clinical trial. The amount of time between submission and approval.